Serum Amyloid A3 Promoter-Luciferase Reporter Mice Are Useful for Early Drug-Induced Nephrotoxicity Detection
Kudo, Ayane, Osedo, Haruka, Aisyah, Rahmawati, Yazawa, Nao, Saliu, Tolulope Peter, Miyata, Kenshu, Kumrungsee, Thanutchaporn, Yanaka, Noriyuki
Published in International journal of molecular sciences (08.05.2024)
Published in International journal of molecular sciences (08.05.2024)
Get full text
Journal Article
Comparative study on molecular mechanism of diabetic myopathy in two different types of streptozotocin-induced diabetic models
Saliu, Tolulope Peter, Kumrungsee, Thanutchaporn, Miyata, Kenshu, Tominaga, Hikaru, Yazawa, Nao, Hashimoto, Kotaro, Kamesawa, Mion, Yanaka, Noriyuki
Published in Life sciences (1973) (01.01.2022)
Published in Life sciences (1973) (01.01.2022)
Get full text
Journal Article
Serum Amyloid A3 Promoter-Driven Luciferase Activity Enables Visualization of Diabetic Kidney Disease
Saliu, Tolulope Peter, Yazawa, Nao, Hashimoto, Kotaro, Miyata, Kenshu, Kudo, Ayane, Horii, Mayu, Kamesawa, Mion, Kumrungsee, Thanutchaporn, Yanaka, Noriyuki
Published in International journal of molecular sciences (14.01.2022)
Published in International journal of molecular sciences (14.01.2022)
Get full text
Journal Article
The serum amyloid A3 promoter-driven luciferase reporter mice is a valuable tool to image early renal fibrosis development and shows the therapeutic effect of glucosyl-hesperidin treatment
Kumrungsee, Thanutchaporn, Kariya, Taishi, Hashimoto, Kotaro, Koyano, Takayuki, Yazawa, Nao, Hashimoto, Takao, Sanada, Yohei, Matsuyama, Makoto, Sotomaru, Yusuke, Sakurai, Hiroaki, van de Loo, Fons A. J., Yanaka, Noriyuki
Published in Scientific reports (01.10.2019)
Published in Scientific reports (01.10.2019)
Get full text
Journal Article